Close
ACHEMA MIDDLE EAST 2026

IoT Making The Precision Lab Equipment Segment See A Surge

It is well to be noted that precision happens to be one of the most required equipment qualities when it comes to consistency as...

Drug Delivery Innovation & Peptide-Stabilized Emulsions

A new study which has been led by Prof. Meital Reches from the Hebrew University, along with Mr. Daniel Boas, one of the Ph.D....

Drug Delivery Innovations Boosting Women-Health All The More

Right from elevating the contraceptive methods to going ahead and improving the treatment of reproductive health issues, drug delivery innovations happen to be paving...

Four Ways To Creating Better Flexible Lab Design Space

Life science companies happen to be facing either a rapid expansion or a consolidation because of the fluctuations in market conditions, the requirement to...

New Molecular Device Opens Door To Targeted Drug Delivery

In one of the newly brought up breakthroughs that could go ahead and even revolutionize medical as well as material engineering, scientists have gone...

Lab Bottlenecks? Digitalized Lab Management Systems Can Help

Analytical as well as research laboratories happen to be at the heart of driving scientific breakthroughs in order to address some of the world’s...

Rare Illnesses: mRNA Therapy May Swap Intracellular Proteins

Notably, the interim data from a Phase I/II clinical trial goes on to suggest that mRNA-3927, which happens to be an investigational mRNA therapy...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...